Skip to content

Effects of transplantation (non-cultured autologous melanocytes) in stable vitiligo plaques.

Effects of transplantation (non-cultured autologous melanocytes) bulge region , dermal papilla and outer root sheet in stable vitiligo plaques.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201203108567N1
Enrollment
10
Registered
2012-03-10
Start date
2012-01-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitiligo. Vitiligo

Interventions

Intervention 1: Intervention group: initially a small areas of the head selected by lidocaine with epinephrine anesthetic is then using a punch mm5 in the area occuipital removed and the bulge and out
Treatment - Surgery
Intervention group: initially a small areas of the head selected by lidocaine with epinephrine anesthetic is then using a punch mm5 in the area occuipital removed and the bulge and outer root sheet an
C - with the other, as seen in the control and the treatment will not be around either.
B - with the other, just insert a needle to create traumaand respond to trauma

Sponsors

Vice chancellor for research, Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 55 Years

Inclusion criteria

Inclusion criteria: Criteria for inclusion: 1) At least 4 years have passed since the onset of their disease. 2) at least 6 months of stable disease and no new leions. 3) The patient's lesions are bilateral.symetric 4) There is not an appropriate response to other therapies. 5) There is no history of disease. Such as hypothyroidism, hyperthyroidism, diabetes, asthma, atopic dermatitis, rhinitis, psoriasis, ulceritive colitis, lupus, alopecia areata, anemia Pernisious ... 6) not currently being treated with other methods. Exclusion criteria: 1) pregnant women. 2) The incidence of these diseases 3) parts of the body that are routinely exposed to light. 4) patients who once responded to NBUVB return is after the break. 5) kelloid

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Repigmentation. Timepoint: One month. Method of measurement: Size and photo.

Secondary

MeasureTime frame
Side effect. Timepoint: During study. Method of measurement: Observation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Shakoei

Dermatology Research Center

dr.shakoei@gmail.com+98 21 2274 1507

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026